Reviews of "Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial"
Year: 2022
Type: peer-review
Abstract: This preprint evaluated the effectiveness of ivermectin in shortening symptom duration or preventing hospitalization in people with mild-moderate COVID-19 symptoms. Both reviewers are in agreement that this study provides strong support for its claim that ivermectin does not seem to provide any clinically significant improvement in treatment outcomes.
Authors: Sandhya Vasan, Edward Mills
Institutions: Henry M. Jackson Foundation, McMaster University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4291378096